SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 2
Abstract
Authors and Affiliations
François D’heygere, Christophe George, Davender Tripathi, Calvin Q. Pan, Jose A. Giron, Manuela Schmitz, Fernando Tatsch
Keywords
Related Articles
- EP ID EP78389
- DOI -
- Views 102
- Downloads 0
Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence
Hepatitis C virus (HCV) is a small, enveloped RNA virus. The number of HCV-infected individuals worldwide is estimated to be approximately 200 million. The vast majority of HCV infections persist, with up to 80% of all c...
Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011
Introduction. High activity antiretroviral therapy (HAART) has allowed people infected with human immunodeficiency virus (HIV) to live longer. In the course of time, hepatocellular carcinoma (HCC) began to be found in th...
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...
Blue-Print for Elimination of Hepatitis C Viral Infection: One Step Closer
-
Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis
Background. T-cell populations regulate the balance of immune responses. The CD (Cluster of differentiation) 4+CD25+ regulatory T cells (Tregs) are crucial for maintaining negative control of various immune responses. T...